Cell and Gene Therapy for Cancer

Cell and gene therapies represent cutting-edge strategies in cancer treatment. CAR-T cell therapy, a type of cell therapy, involves engineering a patient’s T cells to target and destroy cancer cells. Approved for some blood cancers, CAR-T is now being tested for solid tumors. Gene therapy aims to correct genetic mutations or introduce new genes to enhance anti-tumor responses. These therapies offer the potential for long-lasting remissions, especially in cases resistant to traditional treatments. Challenges include manufacturing complexity, cost, and managing immune-related side effects. Continued innovation and clinical research are expanding the scope and safety of these promising treatments.

    Related Conference of Cell and Gene Therapy for Cancer

    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    October 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    Zurich, Switzerland
    November 20-21, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain
    December 08-09, 2025

    13th Euro Breast Cancer and Therapeutics

    Aix-en-Provence, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 23-24, 2026

    16th World Congress on Breast Cancer Research & Therapies

    Aix-en-Provence, France

    Cell and Gene Therapy for Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in